We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLB:NYSESLB Limited Analysis

Data as of 2026-07-07 - not real-time

$45.72

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

SLB is trading at $45.72, just above its 200‑day moving average of $45.43 but below the 20‑day ($50.29) and 50‑day ($53.66) averages, indicating a short‑term pullback within a longer‑term uptrend. The Relative Strength Index of 29 signals oversold conditions, while a bearish MACD histogram suggests lingering downside momentum. Fundamentally, the stock carries a trailing P/E of 20.1 versus an industry average of 19.9, yet its forward P/E of 13.8 points to earnings acceleration, and a dividend yield of 2.6% with a 50% payout ratio underscores cash‑flow strength. The DCF‑derived fair value of $24.6 is well below the market price, flagging a valuation stretch, but analysts project a mean target of $61.8, implying confidence in future growth. Recent news adds a mixed tone: a new OneSubsea contract with BP and an Investor Day focused on AI‑driven digital services highlight growth catalysts, while a sharp oil‑price dip after a US‑Iran peace deal caused a 3.2% intraday drop.
Overall, the stock sits at a crossroads of technical weakness and strong fundamental upside, supported by a solid dividend, moderate debt, and a bullish earnings outlook, but investors must weigh the valuation premium and heightened near‑term volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Oversold RSI suggests potential bounce
  • Support level at $44.59 provides downside cushion
  • Recent oil‑price shock adds short‑term uncertainty

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Digital and AI strategy highlighted at Investor Day
  • OneSubsea contract win expands subsea revenue
  • Forward P/E of 13.8 indicates earnings acceleration

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend yield of 2.6% with 50% payout
  • Strong free cash flow and ROE of 14%
  • Positioning in energy‑transition services and AI‑driven solutions

Key Metrics & Analysis

Financial Health

Revenue Growth2.70%
Profit Margin9.26%
P/E Ratio20.1
ROE14.07%
ROA6.47%
Debt/Equity42.52
P/B Ratio2.6
Op. Cash Flow$6.3B
Free Cash Flow$3.0B
Industry P/E19.9

Technical Analysis

TrendNeutral
RSI29.3
Support$44.59
Resistance$57.92
MA 20$50.29
MA 50$53.66
MA 200$45.43
MACDBearish
VolumeStable
Fear & Greed Index93.13

Valuation

Fair Value$24.64
Target Price$61.82
Upside/Downside35.22%
GradeFair
TypeBlend
Dividend Yield2.61%

Risk Assessment

Beta0.81
Volatility36.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.